Your browser is no longer supported. Please, upgrade your browser.
Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-2.22 Insider Own1.30% Shs Outstand122.90M Perf Week-6.74%
Market Cap7.96B Forward P/E- EPS next Y-1.20 Insider Trans-18.92% Shs Float120.47M Perf Month3.98%
Income-267.80M PEG- EPS next Q-0.51 Inst Own93.10% Short Float9.26% Perf Quarter-0.90%
Sales398.90M P/S19.94 EPS this Y-26.60% Inst Trans6.65% Short Ratio5.23 Perf Half Y26.06%
Book/sh5.84 P/B11.08 EPS next Y20.50% ROA-11.80% Target Price88.00 Perf Year9.97%
Cash/sh9.64 P/C6.71 EPS next 5Y20.00% ROE-21.40% 52W Range37.36 - 81.22 Perf YTD23.20%
Dividend- P/FCF- EPS past 5Y-18.60% ROI-46.30% 52W High-18.63% Beta1.19
Dividend %- Quick Ratio11.70 Sales past 5Y129.90% Gross Margin74.10% 52W Low76.90% ATR4.16
Employees1268 Current Ratio12.10 Sales Q/Q62.90% Oper. Margin-33.40% RSI (14)42.00 Volatility6.56% 5.95%
OptionableYes Debt/Eq0.94 EPS Q/Q-63.90% Profit Margin-35.80% Rel Volume0.52 Prev Close64.73
ShortableYes LT Debt/Eq0.94 EarningsOct 30 AMC Payout- Avg Volume2.13M Price66.09
Recom1.70 SMA20-4.65% SMA50-6.83% SMA20011.99% Volume330,925 Change2.10%
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Jul-26-17Reiterated Lake Street Hold $30 → $41
Jul-26-17Reiterated Canaccord Genuity Buy $42 → $45
May-31-17Reiterated The Benchmark Company Buy $34 → $50
May-31-17Reiterated Canaccord Genuity Buy $38 → $40
Apr-17-17Initiated Leerink Partners Outperform $30
Feb-22-17Upgrade ROTH Capital Neutral → Buy
Feb-21-17Upgrade The Benchmark Company Hold → Buy $17 → $27
Nov-01-16Reiterated Lake Street Hold $8 → $15
Oct-26-16Reiterated The Benchmark Company Hold $14 → $17
Nov-16-18 04:59PM  Better Buy: EXACT Sciences Corporation vs. Illumina Motley Fool
Nov-14-18 07:15PM  Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $11.3 million of Shares GuruFocus.com
Nov-13-18 06:51AM  Todays Research Reports on Stocks to Watch: OPKO Health and Exact Sciences ACCESSWIRE
Nov-09-18 06:00AM  Exact Sciences to participate in two November investor conferences PR Newswire
Nov-06-18 06:32AM  Is Exact Sciences Corporation a Buy? Motley Fool
Nov-05-18 07:25AM  Report: Exploring Fundamental Drivers Behind MRC Global, Exact Sciences, Owens-Illinois, Copart, Cognizant Technology Solutions, and Owens & Minor New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-02-18 04:50PM  Exact Sciences CEO on the Cologuard maker's surge in reve... CNBC Videos
12:40PM  Eaton Vance Worldwide Health Sciences Fund Picks Up 6 Stocks in 3rd Quarter GuruFocus.com
Nov-01-18 04:30PM  Edited Transcript of EXAS earnings conference call or presentation 30-Oct-18 9:00pm GMT Thomson Reuters StreetEvents
01:23PM  Exact Sciences Stock: Buy at What Level? TheStreet.com
08:46AM  Here's What Exact Sciences Just Said About Its Future Motley Fool
Oct-31-18 02:18PM  Why Accuray Is Soaring Today Motley Fool +10.33%
08:20AM  The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Exact Sciences and Illumina ACCESSWIRE
Oct-30-18 06:10PM  Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:03PM  Exact Sciences: 3Q Earnings Snapshot Associated Press
04:05PM  Cologuard® revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter PR Newswire
Oct-29-18 12:09PM  7 Rising Healthcare Stocks to Consider InvestorPlace
Oct-25-18 08:37AM  Implied Volatility Surging for Exact Sciences (EXAS) Stock Options Zacks +5.33%
Oct-18-18 07:00AM  Exact Sciences Strengthens Pipeline Capabilities with Acquisition of Biomatrica, a Leading Provider of Biological Sample Preservation Technology PR Newswire
Oct-16-18 10:41AM  Does Exact Sciences Corporations (NASDAQ:EXAS) Debt Level Pose A Problem? Simply Wall St.
Oct-08-18 06:00AM  Exact Sciences schedules third-quarter 2018 earnings call PR Newswire
Oct-04-18 07:30AM  Detailed Research: Economic Perspectives on Ashland Global, Pattern Energy Group, Jacobs Engineering Group, Olin, Exact Sciences, and Comcast What Drives Growth in Today's Competitive Landscape GlobeNewswire -5.70%
Sep-27-18 06:30AM  3 Stocks That Turned $1,000 Into $23,000 or More in 10 Years Motley Fool
Sep-07-18 06:00AM  Why Exact Sciences Corporation Stock Rocketed Higher in August Motley Fool
Aug-31-18 06:00AM  Exact Sciences to participate in September investor conferences PR Newswire
Aug-24-18 08:00AM  Today's Research Reports on Trending Tickers: Exact Sciences and NovoCure ACCESSWIRE
Aug-23-18 12:57PM  Why Exact Sciences Corporation Stock Is Jumping Again Today Motley Fool
11:39AM  7 Cheap Biotech Stocks to Buy Now InvestorPlace
10:54AM  Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer Zacks
08:00AM  Todays Research Reports on Stocks to Watch: MYnd Analytics and Exact Sciences ACCESSWIRE
Aug-22-18 06:54PM  Exact Sciences CEO talks new partnership with Pfizer CNBC Videos +30.51%
04:41PM  Target and Lowe's jump while Harford Financial falls Associated Press
04:30PM  Why Exact Sciences, Pure Storage, and Zynga Jumped Today Motley Fool
03:58PM  Exact Sciences, Pfizer enter 4-year, $174M co-marketing pact to promote Cologuard American City Business Journals
02:43PM  [$$] Exact Sciences Shares Jump 26% The Wall Street Journal
01:53PM  Four stocks to watch in today's blitz CNBC Videos
10:04AM  Exact Sciences surges after marketing deal with Pfizer for cancer test Reuters
08:55AM  Why Exact Sciences Stock Is Blasting Higher Today Motley Fool
07:13AM  Exact Sciences shares jump 11% premarket on news of Pfizer collaboration on Cologuard MarketWatch
06:15AM  Exact Sciences to host conference call and webcast to discuss its Cologuard co-promotion agreement with Pfizer PR Newswire
06:01AM  Exact Sciences signs marketing deal with Pfizer for cancer test Reuters
06:00AM  Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard® PR Newswire
Aug-17-18 02:42PM  Edited Transcript of EXAS earnings conference call or presentation 1-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-15-18 12:36PM  Exact Sciences begins work on new HQ in Madison's University Research Park American City Business Journals
Aug-13-18 09:00AM  Green Bay Packers and Cologuard Launch "Crossing the 50" Colon Cancer Awareness Campaign PR Newswire
Aug-10-18 03:17PM  GlycoMimetics Stock Has Substantial Upside InvestorPlace
02:00PM  4 Biotech Stocks That May Fall By as Much as 13% Investopedia
Aug-06-18 09:36AM  Is Exact Sciences a Buy on the Dip? Motley Fool
06:00AM  Exact Sciences to participate in Canaccord Genuity Growth Conference PR Newswire
Aug-03-18 08:00AM  Todays Research Reports on Stocks to Watch: DexCom and Exact Sciences ACCESSWIRE
Aug-02-18 06:57PM  Cramer's lightning round: Things are looking up for South... CNBC Videos -12.67%
01:30PM  Exact Sciences' stock drops sharply as Madison company misses analysts' projections American City Business Journals
11:00AM  Tom Lehman Joins Forces with Fight Colorectal Cancer to Raise Awareness of Nation's Second-Leading Cause of Cancer Deaths PR Newswire
07:19AM  Dow Jones Futures Fall On China Trade War Threat; Tesla Leads Big Earnings Movers Investor's Business Daily
06:31AM  Exact Sciences Misses Revenue Estimates by $1.8 Million -- But It Cost the Company a Lot More Motley Fool
Aug-01-18 05:37PM  Exact Sciences: 2Q Earnings Snapshot Associated Press
04:05PM  Cologuard® revenue increased 78 percent to $103 million during second quarter PR Newswire
Jul-25-18 01:10PM  3 'Strong Buy' Healthcare Stocks Poised to Surge TheStreet.com
Jul-12-18 07:25AM  Free Research Reports on DexCom and Three More Medical Research Stocks ACCESSWIRE
Jul-09-18 04:15PM  Exact Sciences to host annual meeting, second-quarter 2018 results webcasts and calls PR Newswire
Jul-07-18 07:15AM  Why Exact Sciences Shares Are Rallying 13.8% in 2018 Motley Fool
Jun-26-18 11:00AM  Nurse Practitioners are Critical Source of Colorectal Cancer Screening Information for Patients, Survey Shows PR Newswire
07:40AM  Research Report Identifies PDL BioPharma, TEGNA, Patterson Companies, Boardwalk Pipeline Partners, Exact Sciences, and Berkshire Hathaway with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jun-21-18 06:00AM  3 Small Cap Stocks That Can Thrive Amid a Trade War Investopedia
Jun-19-18 09:00AM  Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer PR Newswire
08:08AM  Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares Benzinga
Jun-08-18 09:20AM  Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs Benzinga
08:00AM  Exact Sciences Announces Upsizing and Pricing of 1.0% Convertible Senior Notes Due 2025 PR Newswire
Jun-07-18 04:01PM  Exact Sciences Announces Offering of 1.0% Convertible Senior Notes Due 2025 PR Newswire
Jun-06-18 04:10PM  This Biotech Said It Can Detect Liver Cancer In Your Blood And Broke Out Investor's Business Daily
08:38AM  Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate Benzinga
Jun-05-18 04:30PM  Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma PR Newswire
Jun-04-18 08:09AM  20 Million More Potential Customers for Cologuard: Time to Buy Exact Sciences Stock? Motley Fool
07:10AM  Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks ACCESSWIRE
Jun-01-18 01:28PM  Exact Sciences' Cologuard market expands by 20+ million with new American Cancer Society guidelines American City Business Journals
06:00AM  Exact Sciences to participate in June investor conferences PR Newswire
May-30-18 04:29PM  Why Movado Group, Fiat Chrysler Automobiles, and Exact Sciences Jumped Today Motley Fool +11.12%
03:58PM  Exact Sciences Applauds American Cancer Society's Updated Colorectal Cancer Screening Guidelines to Include People Age 45-49 PR Newswire
03:36PM  This News Explains Exact Sciences' Double-Digit Pop Today Motley Fool
02:57PM  American Cancer Society recommends earlier colorectal cancer screening Reuters
02:54PM  Exact Sciences shares surge 11% on earlier cancer screening recommendation MarketWatch
01:26PM  American Cancer Society recommends earlier colorectal cancer screening Reuters
May-29-18 08:18AM  Where Will Exact Sciences Corporation Be in 5 Years? Motley Fool
May-24-18 08:56PM  Where Exact Sciences Corporation (NASDAQ:EXAS) Stands In Earnings Growth Against Its Industry Simply Wall St.
May-14-18 06:00AM  4 Biotech Stocks Set to Rise By 14% or More Investopedia
May-08-18 07:20AM  Recent Analysis Shows Boardwalk Pipeline Partners, Chegg, CommScope Holding, Exact Sciences, HollyFrontier, and Hecla Mining Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-03-18 12:36PM  Exact Sciences teams with Vince Lombardi foundation in fight against colon cancer American City Business Journals
09:00AM  Vince Lombardi Cancer Foundation and Exact Sciences Team Up to Fight Colon Cancer PR Newswire
May-02-18 04:08PM  [$$] Exact Sciences: A Big Opportunity? Barrons.com
May-01-18 06:00AM  Exact Sciences to participate in two investor conferences during May PR Newswire
Apr-30-18 08:43AM  Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher Zacks
Apr-27-18 04:29PM  Why SVB Financial Group, Exact Sciences, and Sprint Jumped Today Motley Fool +11.63%
12:30PM  Why Exact Sciences Is Soaring Today Motley Fool
07:35AM  Edited Transcript of EXAS earnings conference call or presentation 26-Apr-18 9:00pm GMT Thomson Reuters StreetEvents
05:06AM  Exact Sciences: 1Q Earnings Snapshot Associated Press
Apr-26-18 05:11PM  Exact Sciences revenue jumps 87% in first quarter, topping consensus American City Business Journals
04:05PM  Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000 PR Newswire
Apr-25-18 06:02AM  Don't Get Greedy With Exact Sciences Corporation Stock Motley Fool
Apr-13-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Immunomedics ACCESSWIRE
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEONov 12Option Exercise0.83163,514135,7171,049,525Nov 14 05:09 PM
Zanotti Katherine SDirectorNov 12Option Exercise3.437,66726,298109,769Nov 14 05:11 PM
Zanotti Katherine SDirectorNov 12Sale69.007,667529,023102,102Nov 14 05:11 PM
Conroy Kevin TPresident and CEONov 12Sale69.00163,51411,282,466886,011Nov 14 05:09 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 07Sale75.0169852,35728,700Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 05Sale75.0137,6132,821,27629,398Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 01Sale70.3357,5174,045,34267,011Nov 02 05:40 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 31Sale75.3522,1561,669,499124,528Nov 02 05:40 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 08Sale69.3658,0004,022,933146,684Oct 10 04:10 PM
COWARD D SCOTTChief Administrative OfficerOct 01Sale79.512,190174,11875,857Oct 02 04:28 PM
COWARD D SCOTTChief Administrative OfficerSep 30Option Exercise0.004,688078,047Oct 02 04:28 PM
WYZGA MICHAEL SDirectorAug 28Sale74.852,468184,7309,112Aug 30 05:26 PM
Zanotti Katherine SDirectorJul 30Sale58.862,847167,574106,197Aug 01 05:09 PM
Doyle James EdwardDirectorJul 30Sale58.861,31877,57737,093Aug 01 05:06 PM
Fallon John A.DirectorJul 30Sale58.862,373139,67533,767Aug 01 05:07 PM
Carey Thomas D.DirectorJul 30Sale58.863,427201,71348,983Aug 01 05:04 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 30Sale57.788,984519,09632,456Jul 31 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise0.0018,750041,440Jul 31 08:34 PM
COWARD D SCOTTSVP and General CounselJul 02Sale59.102,135126,17673,359Jul 03 04:10 PM
COWARD D SCOTTSVP and General CounselJun 30Option Exercise0.004,687075,494Jul 03 04:10 PM
WYZGA MICHAEL SDirectorMay 10Sale51.537,402381,44710,974May 11 04:48 PM
Zanotti Katherine SDirectorApr 12Sale45.007,232325,440105,814Apr 13 07:06 PM
Doyle James EdwardDirectorApr 10Sale40.973,098126,92535,181Apr 12 04:15 PM
Carey Thomas D.DirectorApr 10Sale39.738,448335,63052,410Apr 12 04:10 PM
COWARD D SCOTTSVP and General CounselApr 02Sale40.122,12285,12467,001Apr 03 04:51 PM
COWARD D SCOTTSVP and General CounselMar 31Option Exercise0.004,688069,123Apr 03 04:51 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 14Option Exercise13.967,16399,995201,112Mar 15 08:58 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 13Sale53.214,464237,529193,949Mar 13 09:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 12Sale52.193,961206,740198,413Mar 13 09:37 PM
COWARD D SCOTTSVP and General CounselMar 12Sale52.192,708141,34164,435Mar 13 04:48 PM
Conroy Kevin TPresident and CEOMar 12Sale52.1911,459598,091882,439Mar 13 04:45 PM
ARORA MANEESHCOOMar 12Sale52.195,295276,367645,089Mar 13 04:43 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 09Option Exercise9.8414,550143,203202,374Mar 13 09:37 PM
COWARD D SCOTTSVP and General CounselMar 09Option Exercise0.006,025067,143Mar 13 04:48 PM
Conroy Kevin TPresident and CEOMar 09Option Exercise0.0024,4000893,898Mar 13 04:45 PM
ARORA MANEESHCOOMar 09Option Exercise0.0011,2750650,384Mar 13 04:43 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 09Sale50.946,125312,001193,949Mar 13 09:37 PM
ARORA MANEESHCOOFeb 27Sale44.105,512243,068639,109Feb 28 07:59 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 27Sale43.6116,688727,712198,808Feb 28 07:58 PM
Conroy Kevin TPresident and CEOFeb 27Sale44.109,085400,630869,498Feb 28 04:44 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Option Exercise5.2327,237142,410220,346Feb 28 07:58 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0020,0250878,583Feb 28 04:44 PM
ARORA MANEESHCOOFeb 26Option Exercise0.0012,1500644,621Feb 28 07:59 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Sale42.2218,337774,248206,596Feb 28 07:58 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Sale42.342,982126,25221,012Feb 27 06:22 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Sale42.347,178303,902206,596Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 26Sale42.3425,3191,071,956858,558Feb 27 06:19 PM
COWARD D SCOTTSVP and General CounselFeb 26Sale42.344,420187,13449,010Feb 27 06:20 PM
ARORA MANEESHCOOFeb 26Sale42.3412,352522,959632,471Feb 27 06:18 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 24Option Exercise0.008,2500213,774Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0019,5000883,877Feb 27 06:19 PM
ARORA MANEESHCOOFeb 24Option Exercise0.0011,0000644,823Feb 27 06:18 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Option Exercise13.7931,825439,020225,774Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250864,377Feb 27 06:19 PM
COWARD D SCOTTSVP and General CounselFeb 23Option Exercise0.0012,850053,430Feb 27 06:20 PM
ARORA MANEESHCOOFeb 23Option Exercise0.0018,8750633,823Feb 27 06:18 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300023,994Feb 27 06:22 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Sale39.7720,250805,364205,524Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 09Option Exercise0.83101,48884,235931,540Feb 13 04:09 PM
Conroy Kevin TPresident and CEOFeb 09Sale45.72101,4884,640,272830,052Feb 13 04:09 PM
Conroy Kevin TPresident and CEOJan 23Option Exercise0.83110,43991,664940,491Jan 25 04:10 PM
Conroy Kevin TPresident and CEOJan 23Sale50.49110,4395,575,961830,052Jan 25 04:10 PM
Conroy Kevin TPresident and CEOJan 12Option Exercise0.83125,402104,084955,454Jan 17 04:07 PM
Conroy Kevin TPresident and CEOJan 12Sale52.79125,4026,620,593830,052Jan 17 04:07 PM
COWARD D SCOTTSVP and General CounselJan 03Sale52.541,66587,47440,580Jan 04 05:32 PM
COWARD D SCOTTSVP and General CounselJan 02Option Exercise0.004,687042,245Jan 04 05:32 PM
Conroy Kevin TPresident and CEODec 22Option Exercise0.83123,512102,515953,564Dec 26 04:18 PM
Conroy Kevin TPresident and CEODec 22Sale52.58123,5126,494,790830,052Dec 26 04:18 PM
Conroy Kevin TPresident and CEODec 06Option Exercise0.83121,849101,135951,901Dec 08 04:15 PM
Conroy Kevin TPresident and CEODec 06Sale53.45121,8496,513,179830,052Dec 08 04:15 PM
LIDGARD GRAHAM PETERChief Science OfficerDec 01Sale58.2745,7702,667,204193,949Dec 04 04:23 PM